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ABSTRACT 
Single-molecule FRET Analysis of the Dynamics of AMP A Receptor 
by 
Ferandre C. Salatan 
Single-molecule fluorescence resonance energy transfer (smFRET) spectroscopy has 
advanced to become a powerful tool in characterizing biomolecules to the molecular level. In 
this thesis, the smFRET technique was utilized for the first time to analyze the dynamics of 
the conformational changes of the ligand-binding domain (S1S2) of GluR2, a subunit of the 
ionotropic glutamate/AMPA receptor. The GluR2-SlS2 molecule was determined to have a 
more open cleft when the natural ligand glutamate is not present as compared to when 
glutamate is bound to the molecule. The apo and Glutamate-bound GluR2-SlS2 molecules in 
solution medium were observed to have more open cleft than when they are in crystallized 
forms. The smFRET technique has an advantage over x-ray crystallography because it can 
quantitatively analyze the conformations of the molecules and the interconversions between 
those states. The dynamics of the GluR2-SlS2 molecule elucidates the mechanism of 
activation of glutamate receptors. 
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1. INTRODUCTION 
The idea of an energy transfer from a donor fluorophore to an acceptor fluorophore 
through the interaction between the rotating dipoles of the fluorophores was conceptualized 
by Forster in 19481. Based on Forster's derivation, the rate of the energy transfer is inversely 
proportional to the sixth power of the distance between the rotating dipoles of the 
fluorophores. This relationship was later used to calculate the Forster or Fluorescence 
Resonance Energy Transfer (FRET) efficiency from a donor fluorophore to an acceptor 
fluorophore (Equation 1). 
E= (l+ (j-] J (Equation 1) 
where: E = efficiency of energy transfer from donor to acceptor fluorophore 
R = distance between fluorophores 
Ro = Forster radius or distance between fluorophores where E = 0.5 
Although the inverse proportionality was proposed in 1948, it was only in 1967 when the 
energy transfer was proven to be dependent on the distance between the two fluorophores2. 
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Stryer and Haugland used poly-L-proline oligomers (Figure 1) of different lengths to further 
investigate Forster's equation. They attached the donor (a-naphthyl group) at the carboxyl 
end and the acceptor (dansyl group) at the imino end of the polypeptide oligomers. They 
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observed that the efficiency of the energy transfer (E) is consistent with the sixth power 
inverse dependence calculated by Forster . The inverse relationship between the inter-dye 
distance and the efficiency of the energy transfer made the FRET technique an excellent tool 
in describing the average conformations adopted by the molecules based on the proximity of 
the two fluorophores. 
The FRET technique is highly dependent on the use of fluorophores. The ideal dye 
molecule should be bright and photostable3. Moreover, a fluorophore pair should have widely 
separated donor and acceptor emissions and should have almost the same quantum yields3. 
The most popular dyes are Cy3 and Cy5 although other dyes such as Alexa555 and Alexa647 
also have comparable properties. In fact, Alexa647 has even brighter emission than Cy53. 
The Alexa555 (donor dye) has a maximum emission at 567 nm and Alexa647 (acceptor dye) 
at 667 nm (Table 1). 
Table 1. Comparison of Fluorophores 
Fluorophore 
Alexa555 
Alexa647 
Excitation A,max (nm) 
555 
650 
Emission A,max (nm) 
567 
667 
The power and resolution of FRET technique was even more enhanced by some 
developments in single-molecule spectroscopy " . Our research group's single-molecule 
FRET (smFRET) setup requires the use of light source, optical microscope and objective, 
scanning stage, CCD camera, photodiodes, counting and imaging computer boards, and 
filters. The light source excites the donor dye and it should be monochromatic, hence the use 
of LASER light source. The LASER excitation light is directed to an optical microscope 
where an objective focuses the light to the sample. The scanning xyz piezo stage positions 
each molecule to be excited by the incoming focused light. The CCD camera is used to 
monitor the tightness of the focused light that excites the sample. The same objective collects 
the fluorescence that is split into donor emission and acceptor emission. The emitted photons 
are detected by photodiodes that are connected to counting and imaging computer boards. 
The smFRET technique can now analyze the movements occurring within an 
individual molecule or the movements during the binding of two molecules. This technique 
has been previously used in nucleotide analysis to observe the folding pathways and 
dynamics of nucleotides9"15, to evaluate the possible intermediates produced by the 
interaction16 or dissociation of nucleotides17, to study the mechanism of the opening of DNA 
hairpins18 in the absence or presence of an inhibitor19, and to characterize the reaction 
9f) 94 9 S 98 
between complementary nucleotides " and between a nucleotide and a protein " . The 
technique has also been used in protein analysis to investigate conformational dynamics of 
protein folding29"40 and enzyme catalysis29' 41, to determine the presence of different 
conformational states 2" 5, and to observe the interaction between two proteins4 . However, 
the technique has never been used to analyze the protein folding of the extracellular ligand-
binding part of glutamate receptors. 
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Glutamate receptors are imbedded in the membranes of neurons47 and they act as 
mediators for a number of neurotransmission functions48"51 by forming an ion channel when 
the neurotransmitter Glutamate (Figure 2) binds to the extracellular ligand-binding domains 
of the receptors. However, if they are overstimulated by an excessive amount of Glutamate, 
,52, 53 they will eventually degenerate and die ' . The death of neurons may be involved in some 
diseases of the central nervous system (CNS) 54 
The two types of glutamate receptors are the ionotropic and the metabotropic55. The 
ionotropic glutamate receptors (iGluRs) have integral ion channels47 while the metabotropic 
glutamate receptors (mGluRs) activate G-proteins56. The iGluRs are usually found in the 
brain 7. They mediate excitatory responses by opening the ion channels and driving the 
neurons to depolarize. Since they are located in the synapses between neurons, they are 
important in memory and learning57. The iGluRs are classified into three major categories 
based on the characteristics of activation by different agonists: AMPA receptors, kainate 
receptors, and NMDA receptors55'58. 
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Figure 3. GluR2 subunit of the AMPA Receptor 
This diagram shows the part of the subunit that is 
yv Domain 1 included in the construction of the GluR2-SlS2 
'\(/ molecule. The Glycine-Threonine (GT) linker was 
f l^A added to preserve the 3D structure of the GluR2-
Domain2 S1S2 molecule. 
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The AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazole propionate) receptor is 
composed of four subunits60, which include GluRl, GluR2, GluR3, or GluR447 (also called 
GluR-A, GluR-B, GluR-C, or GluR-D)58, to form one ion channel. However, the majority of 
the AMPA receptors in the CNS are heterotetramers that consist of GluRl-GluR2 dimers or 
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GluR2-GluR3 dimers61. The GluR2 subunit (Figure 3) is the most common subunit in all the 
CO S 1 
AMPA receptors (AMPARs) * . One subunit contains the amino terminal domain (ATD) 
and the ligand-binding domain (S1S2), which are located outside of the cell. It also has 
transmembrane domains 1, P, 2 and 3 that form the ion channel and the carboxy terminal 
domain (CTD) inside the cell59. The cleft between SI and S2 is occupied by glutamate, the 
natural ligand of the AMPARs. Of the two lobes of the ligand-binding domain, one is rigid 
while the other is flexible62. Moreover, the closed conformation of the ligand-binding 
domain was found to be stabilized by the interlobe salt bridge interaction between the 
Glutamate at position 705 (E705) and the Lysine at position 730 (K730) . The above 
structural correlations were determined using molecular dynamics (MD) simulations. 
Another interaction across the cleft is the formation of hydrogen bond between the Glutamate 
at position 402 (E402) and the Threonine at position 686 (T686)63 when the ligand Glutamate 
is bound. This interaction was identified using Monte Carlo simulations. When T686 is 
replaced with Serine (S), the mutation weakens the closed conformation of the Glutamate-
bound GluR2-SlS2-T686S63'64. 
One AMPA receptor is a dimer of dimers, hence it has four binding domains60. When 
two subunits are occupied by one Glutamate molecule each, the result is only low 
conductance ion channel opening. However, when three or four subunits are occupied, there 
is a higher conductance level of ion channel opening °' 5' . The AMPARs are fully activated 
by AMPA and Glutamate, and are partially activated by kainate58. An earlier study on the 
crystal structures of GluR2-S 1S2 revealed that the two lobes are nearest to each other if the 
ligand is Glutamate or AMPA; but they are farthest from each other if there is no ligand . In 
a similar study using crystal structures of GluR2-SlS2 - ligand complexes, full agonists 
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stabilize a fully closed cleft, antagonists stabilize an open cleft similar to the apo state, and 
partial agonists induce intermediate degrees of cleft closure68. 
When the ligand Glutamate is inside the ligand-binding cleft of the GluR2-SlS2 
molecule, it interacts with the two lobes (SI and S2) through hydrogen bonds and salt 
bridges67. These interactions were determined through crystallography. The a-carboxyl group 
of the ligand Glutamate forms hydrogen bonds with Arginine at position 485 (R485) in SI, 
Threonine at position 480 (T480) in SI, and Serine at position 654 (S654) in S2. The a-
amino group of the ligand Glutamate forms salt bridges with Proline at position 478 (P478) 
in SI, Threonine at position 480 (T480) in SI, and Glutamate at position 705 (E705) in S2, 
and these interactions significantly affect the degree and stability of cleft closure69, 70. The 
ligand Glutamate causes a conformational change in GluR2-SlS2 molecule that results in the 
71 
closing of the cleft. In contrast, antagonists keep the ligand-binding cleft open leaving the 
ion channel closed72. This property of the antagonists makes them potential neuroprotective 
agents because they can prevent excessive excitation of the neurons73"78. 
There is a notion that the cleft closure of GluR2-SlS2 is not rigid in solution. Instead, 
it has been suggested to be a dynamic equilibrium between two or more conformations65'66' 
7i, 79, so Qn e r e s e a r c n gr0Up observed that the solution conformation of some GluR2-SlS2 -
ligand complexes with partial agonists differ from those observed in the crystal structure81. 
When an agonist binds to GluR2-SlS2, the ligand-binding cleft closes and the resulting 
conformational change leads to the opening of the ion channel gate65'82. This statement is 
supported by x-ray crystallographic and single-channel data83. Using molecular dynamics 
(MD) simulations, the opening of the ligand-binding domain is coupled to the conformational 
changes in the transmembrane domains84 and the Glutamate at position 209 (E209) was 
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identified as the critical residue that triggers channel opening85. Therefore, the extent of 
activation of the AMPAR can be correlated to the extent of cleft closure induced by an 
agonist67'79-86. 
The smFRET technique can quantify the degree of cleft closure in the GluR2-SlS2 
molecule and the dynamics of this process. This technique measures the non-radiative energy 
transfer between two fluorescent dye molecules (donor and acceptor) that are attached to 
each lobe of the GluR2-SlS2 molecule. The energy transfer between the two fluorophores 
takes place only when they are properly oriented, are within 10 nm of each other, and have 
resonant or almost equal energy gaps of their molecular orbitals. The FRET efficiency, which 
can be calculated from the ratio of acceptor intensity to total emission intensity, reports the 
distance between the two fluorophores. The two dyes that lie closer to each other have higher 
FRET efficiency. 
In this thesis, I report the successful expression of GluR2-SlS2 protein in bacterial 
cells and the labeling of the said protein with Alexa555 and Alexa647. Those important tasks 
were accomplished by our collaborators at the University of Texas Health Science Center. I 
also report our pioneering analysis of the conformational changes of immobilized single 
GluR2-SlS2 molecules, particularly the opening and closing of the ligand-binding cleft, by 
using smFRET technique. The donor and acceptor emission trajectories were collected and 
denoised by wavelet analysis before the FRET efficiency was calculated. The characteristic 
time scale of the FRET efficiency fluctuation is determined by calculating the autocorrelation 
function of the FRET efficiency and fitting it to the exponential decay function. 
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Hidden Markov Model (HMM) analysis87 was done to further characterize the 
conformations of the molecule in the presence or absence of Glutamate. This process is based 
on the assumption that the conformational states of GluR2-SlS2 are not directly observable 
from the smFRET trajectories. This process calculates the probability of future 
conformational states from the sequence of the past to current conformational states. 
We determined that the ligand Glutamate closes the cleft between SI and S2 and 
stabilizes the GluR2-SlS2 molecule. Moreover, the Glutamate-bound GluR2-SlS2 has four 
preferred conformational states as predicted by MD simulations64 while the apo GluR2-SlS2 
has five. Lastly, the T686S mutation resulted in a more loose interaction between the two 
lobes. 
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2. EXPERIMENTAL SECTION 
2-1. Expression and Labeling of GluR2-SlS2 
The GluR2-SlS2 molecule (Figure 3) that was used in the experiments was 
reconstructed from the GluR2 subunit by deleting the ATD88'89, cutting the sequences before 
the transmembrane (TM) domains, and stitching the two amino acids above TM 1 and TM 2 
by adding a Glycine-Threonine (GT) linker . This linker connects the Lysine at position 
506 (K506) and the Proline at position 632 (P632)81. This method of designing the 
extracellular ligand-binding molecule for experimental use was developed by Kuusinen, et al. 
in 1995 to produce GluR4-SlS290. Gouaux, et al. used the same method of adding a linker to 
produce GluR2-SlS259. The plasmid of the above GluR2-SlS2 construct was generously 
given to our collaborators at the University of Texas Health Science Center by Dr. Eric 
Gouaux of the Oregon Health and Sciences University, Portland, OR. 
The expression and labeling of GluR2-SlS2 protein were done by our collaborators at 
the University of Texas Health Science Center and their experimental procedures are 
described in this thesis. The GluR2-SlS2 plasmid was mutated to replace two amino acids, 
Threonine at position 394 (T394) and Serine at position 652 (S652), with Cysteine (C) and to 
add eight Histidine residues (Histag) at the N terminus91. The new construct (Histag-GluR2-
S1S2-T394C-S652C plasmid) was inserted into the genome of Escherichia coli Origami B 
(DE3) cells using the vector pET24g. These bacterial cells were used to express the protein. 
Although the GluR2-SlS2 molecule is expressed in bacterial cells, it was observed that it is 
still similar to the intact receptor in its ligand-binding ability92. After incubation, the bacterial 
cells were lysed and the lysate was purified using a Ni-NTA HiTrap column69. The said 
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column has a high affinity for the polyhistidine-tagged GluR2-SlS2 protein. Buffered 
imidazole solution was added to the column to displace the GluR2-SlS2 protein. 
Another mutant construct Histag-GluR2-SlS2-T394C-S652C-T686S where Serine 
residue replaced the Threonine at position 686 (T686S) was used. The T394C, S652C, and 
T686S mutations were introduced by using the QuikChange site-directed mutagenesis kit 
(Stratagene). All mutations were verified by analyzing the DNA sequence of each construct. 
The GluR2-SlS2 molecules were tagged with Alexa dyes using a previously reported 
method69' 70' 91. The Glutamate-bound GluR2-SlS2 molecules were dissolved in a solution 
containing 1:3 molar ratio of the maleimide derivatives of Alexa555 and Alexa647. The thiol 
group of each C residue reacted with one maleimide-conjugated Alexa dye. To prepare a 
sample of apo GluR2-SlS2 molecule, the labeled protein was dialyzed against phosphate-
buffered saline (PBS) to remove the bound Glutamate. 
2-2. Immobilizing and Protecting GluR2-SlS2 
Glass slides were immersed in acetone and subsequently sonicated for 5 minutes. 
They were plasma-cleaned for 2 minutes to remove the dirt and impurities on the surface. 
After plasma-cleaning, they were soaked in 2% v/v Vectabond in acetone solution for 5 
minutes. Vectabond, an aminosilane, was used to put a layer of amine function on the surface 
(Figure 4). The amine group of the Vectabond reacted with the NHS ester group of 0-[2-(N-
Succinimidyloxycarbonyl)-ethyl]-0'-methylpolyethylene glycol 5000 (NHS-PEG-5000) and 
NHS-PEG-5000-Biotin (biotin-PEG). A sample chamber was assembled by sticking a 
coverslip with two ports on top of the functionalized glass slide (Figure 4). The two ports 
were used as inlet and outlet ports for the flow system. The GluR2-SlS2 was attached to a 
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biotin-conjugated anti-histidine monoclonal antibody (biotin-Anti-His Ab). The biotin-PEG 
slide was incubated with streptavidin (SA) solution. The SA served as the linker between the 
biotin-PEG slide and the biotin-Anti-His Ab - GluR2-SlS2 complex. 
The glass surface (Figure 4), where GluR2-SlS2 molecules are to be immobilized, 
was first aminosilanized through Vectabond before it was coated with a monolayer of a 
mixture of PEG and biotin-conjugated PEG (biotin-PEG). The PEG was used to passivate the 
surface so that the GluR2-SlS2 molecules would not stick to the glass. The biotin-PEG was 
used for sparse tethering. The immobilization of GluR2-SlS2 molecules on the 
functionalized surface was made possible by the specific binding of streptavidin to biotin. 
One streptavidin molecule can bind four biotin molecules. To minimize the possibility of 
having more than one GluR2-SlS2 molecule in one streptavidin, we used a low 
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concentration of only 2 nM for the GluR2-SlS2 solution. Moreover, the biotin-conjugated 
antibody molecules that did not react to GluR2-SlS2 molecules did bind to streptavidin, thus 
reducing the possibility of the binding of more than one GluR2-SlS2 molecule in one 
streptavidin molecule. 
Molecular oxygen must be removed from the sample chamber to protect the 
fluorophores from any reaction that will render them unable to fluoresce. The oxygen 
scavenging flow solution was prepared by following an established protocol . The flow 
solution was composed of 3% (wt/vol) (3-D-(+)-glucose (Sigma), 0.1 mg of glucose oxidase 
(Roche Applied Science) per ml of solution, 0.02 mg of catalase (Roche Applied Science) 
per ml of solution, 2 mM MgCb, and saturated solution of Trolox powder (6-hydroxy-
2,5,7,8-tetramethylchroman-2-carboxylic acid; Fluka)3. The Trolox powder was dissolved in 
PBS, and then subsequently filtered. 
To enhance the photostability of the dyes during the smFRET experiment, molecular 
oxygen should be removed from the system. Molecular oxygen can be a source of highly 
reactive oxygen species (ROS) such as superoxide anion and hydroxyl radical that may react 
with the 7i electrons of the aromatic functional groups of the fluorophores. Since fluorescence 
is associated with the transition of electrons from 7t to 7t* level, the removal of n electrons 
can cause more immediate photobleaching of the fluorophores. The enzymatic oxygen 
scavenging system is composed of glucose, glucose oxidase, and catalase ' . We added 
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid), an analog of Vitamin E , 
because it also helps in reducing photobleaching3'95'96. The glucose oxidase catalyzes the 
reaction between glucose and molecular oxygen to produce glucono-l,5-lactone and 
hydrogen peroxide. Catalase decomposes hydrogen peroxide into water and oxygen but in 
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the presence of radiation, hydrogen peroxide decomposes into hydroxyl radicals. Trolox then 
scavenges the resulting free radicals. Moreover, Trolox is also an antiblinking agent because 
it can quench the triplet excited state and can transfer its electron to the fluorophore to 
recover the singlet excited state96. 
2-3. FRET Instrumentation 
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Figure 5. FRET Instrument26. The LASER source has a wavelength of 532 nm. The 
power of the light going to the sample is regulated by using variable optical density filters. 
The light is directed to the sample through a dichroic mirror (532 nm high-pass). The 532-
nm band-stop removes the excitation light from the fluorescence light before it passes 
through the notch filter (focusing lens). Another dichroic mirror (640 nm high-pass) splits 
the fluorescence light into donor emission and acceptor emission. The additional filters 
(bandpasses) in front of the detectors improve the signal to noise ratio of the emissions. 
A diagram of our FRET instrumentation used in previous works ' is shown in 
Figure 5. The sample chamber with flowing oxygen scavenging solution sat on top of a 
closed-loop x-y-z piezo stage (P-517.3CL; Physik Instrumente) with 100 x 100 x 20 urn 
travel range and 1-nm specificity (SPM 1000; RHK Technology). The sample was excited 
using 532-nm solid state LASER light (Verdi; Coherent). The power of the LASER light was 
controlled as necessary using neutral density filters. The excitation light should have a 
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Gaussian beam profile at the sample. This was achieved by expanding the excitation light to 
overfill the back aperture of a FLUAR lOOx 1.45 NA oil immersion microscope objective 
(Carl Zeiss, GmBH)98. The expansion resulted in a 1/e2 beam radius of ~250 nm and height 
of ~1 urn. 
Fluorescence was collected and refocused by the same objective" and was separated 
from the excitation light by using a dichroic mirror (z532rdc, Chroma Technology). The S/N 
ratio was further improved by a notch filter (NHPF-532.0; Kaiser Optical) and an emission 
filter (ET585, Chroma Technology). The signal was refocused and passed through a second 
dichroic mirror (640-nm high-pass filter) to separate the donor emission from the acceptor 
emission. The donor and the acceptor fluorescence signals were collected by two 
corresponding avalanche photodiode detectors (SPCM-AQR-15; Perkin-Elmer). 
2-4. Data Collection and Analysis 
The GluR2-SlS2 molecules were excited by green LASER light (532 nm). Each 
emission trajectory (Figure 6) was collected at a 1-ms resolution and later binned up to 10 ms 
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to enhance the S/N ratio. The fluorescence signals of the donor (/D) and the acceptor (/,,) 
were collected until the fluorophores were photobleached. The apparent FRET Efficiency 
(EA) was calculated by Equation 297 using the background- and crosstalk-corrected and 
denoised intensities. 
EA =
 VJI+W (Equation 2) 
In the crosstalk region, the acceptor dye is already photobleached but the number of 
acceptor photons in this region is still higher than that in the background region. It is because 
the donor photons leak into the acceptor detector and are counted as acceptor photons. We 
need to determine the number of the donor photons in the acceptor count (nx) by calculating 
the crosstalk parameter, x . The background- and crosstalk-corrected intensities are 
calculated by the following equations: 
(4 = NA ~ bA — nx (Equation 3) 
h = ND — bD + nx (Equation 4) 
where: NA = number of acceptor photons in the FRET Region 
ND = number of donor photons in the FRET Region 
bA = number of acceptor photons in the Background Region 
bD = number of donor photons in the Background Region 
The intensities were denoised through wavelet transform or wavelet analysis . This is 
done by first transforming the signal, the donor or acceptor trajectory in this case, from a 
time domain signal to a frequency domain signal. It is followed by decomposing the 
frequency domain signal into low frequency component and high frequency component. The 
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low frequency component is further decomposed into low frequency component and high 
frequency component. The wavelet function is generated from a wavelet of the low 
frequency component that is dilated/scaled in frequency by a to match the original frequency 
domain signal and translated/shifted in time by b. The wavelet coefficient (W) is calculated 
(Equation 5) and it shows the correlation between the original frequency domain signal and 
the wavelet. 
W(a,b) = Va S^f * (a x a))h(o))eicobdo) (Equations) 
where: xp = Fourier transform of the wavelet 
h = Fourier transform of the signal 
co = 2nv (v is frequency) 
Then a threshold wavelet coefficient is defined97. If the wavelet coefficient of the low 
frequency component after the last signal decomposition is lower than the threshold wavelet 
coefficient, then that component is only a noise. The signal is reconstructed without the noise 
component. 
Since the cleft closure of the GluR2-SlS2 is floppy in solution, the molecule is in a 
state of dynamic equilibrium between two or more molecular conformations 5' 6 ' 7 ' °. 
Therefore, it is necessary to identify the conformational states using Hidden Markov 
Modeling (HMM). This analysis considers the FRET trajectories as Markov processes with 
unobserved or hidden states and it determines the distributions of states and the 
corresponding interconversion rates87 and rate constants. Our research group uses the 
HaMMy program97 to do this analysis. 
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It is also important to determine the FRET efficiency fluctuation characteristic time 
scale of the molecule. This was done by executing an autocorrelation analysis100 (Equation 6) 
on the FRET Efficiency of each molecule, then by taking the average of all the 
autocorrelation functions, C(T) to produce an ensemble. 
G(j) = ^ ^ (Equation 6) 
where: SF(t) = F(t) - (F(t)) 
F(t) = FRET efficiency at time t 
(F(t)) = average FRET efficiency 
r= lag time 
SF(t + r) = F(t +r)- (F(t)) 
F(t + r) = FRET efficiency at time t shifted by T 
The collected data were analyzed with programs written by James Nick Taylor and 
Carmen Reznik using MATLAB (R2008a). 
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3. RESULTS AND DISCUSSION 
The ideal GluR2-SlS2 molecule with one donor dye and one acceptor dye is depicted 
in Figure 7. The maleimide-conjugated Alexa555 and Alexa647 are attached to the GluR2-
S1S2 molecule through the two Cysteine residues that replaced T394 and S652. There are 
two inherent C residues (C425 and C436), and so the addition of two C residues (T394C and 
S652C) makes it possible to produce molecules with more than two fluorophore labels. 
Figure 7. Structure of GIuR2-SlS2 . 
The GluR2-SlS2 plasmid was modified to 
express eight Histidine residues (His tag) at 
the N terminus and two Cysteine (C) residues 
to replace T394 in Lobe I (SI) and S652 in 
Lobe II (S2). The thiol (-SH) groups of the 
two C residues were used to attach the 
maleimide-conjugated donor dye (Alexa555) 
and acceptor dye (Alexa647) to the S1S2 
molecule. The neurotransmitter Glutamate 
occupies the ligand-binding cleft. 
However, the C425 and C436 residues were previously observed by our collaborators at the 
University of Texas Health Science Center to be inaccessible to fluorophore labeling using 
terbium chelate and fluorescein91. Our collaborators successfully labeled the majority of the 
GluR2-SlS2 molecules with one donor dye (D) and one acceptor dye (A). We found out that 
there are not so many multilabeled GluR2-S 1S2 molecules (Table 2) because 74% of the apo 
GluR2-SlS2, 78% of the Glutamate-bound GluR2-SlS2, and 86% of the Glutamate-bound 
GluR2-SlS2 molecules have one pair of fluorophores. The number of attached fluorophores 
can be deduced from the emission trajectory of a molecule. 
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Table 2. Percentages of Labeled Molecules 
Molecule 
ApoSlS2 
SlS2 + Glu 
SlS2-T686S + Glu 
1D:1A 
74% 
78% 
86% 
2D:1A 
21% 
17% 
14% 
1D:2A 
3% 
4% 
0% 
2D:2A 
2% 
1% 
0% 
The emission trajectory of a molecule with one donor dye and one acceptor dye 
shows a single-step photobleaching event for each of the donor and acceptor emissions. If 
there are two donor dyes and one acceptor dye in a molecule (Figure 8A), its emission 
trajectory shows two-step photobleaching events for the donor emission (Figure 9A). 
Moreover, in the FRET region, one donor dye is transferring its energy to the acceptor dye 
while the other one is emitting photons, which means that it is farther than 10 nm from the 
acceptor dye. This results in a lower FRET efficiency. Generally, the presence of multiple 
dyes affects the calculated FRET efficiency values. 
20 
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Figure 9. Sample emission trajectories of multilabeled GluR2-SlS2 molecules. The 
donor emission is blue ( BUS) while the acceptor emission is red ( Bil l ) . All of these 
emission trajectories were collected from Glutamate-bound S1S2 molecules. (A) Molecule 
with two donor dyes and one acceptor dye. (B) Molecule with one donor dye and two 
acceptor dyes. (C) Molecule with two donor dyes and two acceptor dyes. (D) Molecule 
with only donor dye. 
From Figure 9C, we can see that there are two donor and two acceptor dyes in the 
molecule (Figure 8C) where this emission trajectory was collected. There is a transfer of 
energy at first from the two donor dyes to the two acceptor dyes. When one acceptor dye is 
photobleached, the number of donor photons increased because one donor is not near enough 
to transfer its energy to the remaining acceptor dye while the other donor dye is still 
transferring its energy to the remaining acceptor dye. 
Figure 9D shows an emission trajectory of a donor-labeled molecule. It is possible 
that there is only one donor dye attached to the molecule because there is only one 
photobleaching event. On the other hand, if the molecule is labeled with acceptor dye only, 
that molecule will have very weak emission intensity because it will not be optimally excited 
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by the 532-nm LASER light. Finally, all the multilabeled molecules were excluded from the 
ensemble analysis. After the purging of data, the respective FRET ensemble histograms 
included 41 apo GluR2-SlS2 molecules, 67 Glutamate-bound GluR2-SlS2 molecules, and 
60 Glutamate-bound GluR2-SlS2-T686S molecules. 
200 
<D ; cr = 0.03 
Figure 10. Single-molecule Emission Trajectory. One molecule is excited by 532-nm 
LASER light. (A) The energy transfer from the donor dye to the acceptor dye results in the 
high acceptor emission (ifgsn) photon count until the acceptor dye is photobleached. The 
donor dye is more photostable so the donor emission ( BB1) takes longer time until the 
donor dye is photobleached. Some of the donor emission photons leak into the acceptor 
detector and are counted as acceptor emission photons. (B) The resulting single-molecule 
FRET trajectory from A is shown in red (EHH) while the denoised FRET trace is shown in 
blue (HHI). (C) The corresponding FRET histogram shows the average FRET efficiency 
and the standard deviation of the denoised signal. 
One molecule is excited by the 532-nm LASER light; then the emission trajectory 
(Figure 10A) is collected. When the donor is transferring its energy to the acceptor, high 
acceptor (red) photon count is observed and this part of the emission trajectory is called the 
FRET region. When the acceptor is photobleached, a rise in the donor (blue) photon count is 
observed in the crosstalk region because the donor dye is more photostable than the acceptor. 
The donor and the acceptor are both photobleached in the background region. In the crosstalk 
22 
region, we estimate the portion of the donor photons that leak into the acceptor detector and 
are counted as acceptor photons by calculating the crosstalk parameter . We use the 
crosstalk parameter to correct the donor and acceptor emission intensities in the FRET region 
before we calculate the average FRET efficiency «EA» of each GluR2-SlS2 molecule using 
the denoised signal (Figure 10B). The FRET trajectory in Figure 10B is a result of the 
denoised donor and acceptor trajectories. The denoising was done by using a process called 
wavelet transform or wavelet analysis . The histogram shown in Figure 11A is the 
raw/observed histogram that represents the FRET trajectory in Figure 10B. The histogram 
shown in Figures IOC and 1 IB is based on the denoised FRET trajectory in Figure 10B. 
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Figure 11. Single-molecule 
FRET Histograms. 
(A) The raw histogram 
before the donor and 
acceptor trajectories are 
denoised. (B) The resulting 
histogram after denoising the 
donor and acceptor 
trajectories by wavelet 
analysis. 
The wavelet analysis program developed by James Nick Taylor, a member of our 
research group, notably sharpens the resolution of a signal by removing the shot noise 
component as shown in Figure 11. The removal of the noise component does not greatly 
affect the average FRET efficiency of the reconstructed signal as observed in the single-
molecule FRET histogram (Figure 11). 
The histograms of individual molecules are taken together to generate one ensemble 
histogram (Figure 12). The raw/observed histograms (Figures 12A, 12C, and 12E) are broad 
and featureless. But the denoising process by wavelet analysis decreased the a or the 
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distribution of FRET efficiency values without changing the average FRET efficiency values 
of the three molecules. Moreover, the denoised histograms (Figures 12B, 12D, and 12F) 
show more pronounced peaks compared to the raw/observed histograms. Those peaks reveal 
the possible conformations that the GluR2-S 1S2 molecule prefers to adapt when the ligand 
Glutamate is bound or not bound to the molecule. 
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Figure 12. Observed and Denoised Ensemble FRET Histograms. (A) Observed apo 
GluR2-SlS2, 41 molecules. (B) Denoised apo GluR2-SlS2. (C) Observed Glutamate-
bound GluR2-SlS2, 67 molecules. (D) Denoised Glutamate-bound GluR2-SlS2. 
(E) Observed Glutamate-bound GluR2-SlS2-T686S, 60 molecules. (F) Denoised 
Glutamate-bound GluR2-SlS2-T686S 
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Based on the crystal structure of apo GluR2-SlS2, the distance between T394 and 
S652 is around 3.7 nm91. In solution medium, the apo GluR2-SlS2 has an average FRET 
efficiency of 0.74 (Figure 12B), which translates to an average inter-dye distance of around 
4.28 nm. The dyes were attached to T394C and S652C. Our observation that the apo GluR2-
S1S2 in solution can be more open than when it is in the crystal structure is very much in 
agreement with the computations done by Lau and Roux64. The same is true for the 
Glutamate-bound GluR2-SlS2. The T394 - S652 distance in the crystal structure is around 
3.1 nm91. In solution medium, the Glutamate-bound GluR2-SlS2 has an average FRET 
efficiency of 0.80 (Figure 12D), which means that the average inter-dye distance is around 
4.05 nm. 
It is expected that the apo GluR2-SlS2 is more floppy than the Glutamate-bound 
GluR2-SlS2 due to the absence of the ligand. Based on the average FRET efficiency values, 
the apo GluR2-SlS2 has a more open cleft than the Glutamate-bound GluR2-SlS2. 
Moreover, based on the a or the distribution of FRET efficiency values, the apo GluR2-SlS2 
has a broader distribution (a = 0.13) of inter-dye distances than the Glutamate-bound GluR2-
S1S2 (a = 0.10). Although the cleft of the Glutamate-bound GluR2-SlS2 is relatively more 
closed, the molecule is still floppy as shown by the wider range of its FRET efficiency values 
compared to the more stable HIV-1 TAR-DNA molecule18'26 (a = 0.06) in Figure 13. 
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Figure 13. Denoised HIV-1 TAR-
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This is a histogram of 29 molecules. 
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value of 0.95; Structure of HIV-1 
TAR-DNA with the attached donor 
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The T686S mutation indeed resulted in a weaker connection between SI and S2 
(Figure 12F). The consequence of this mutation is seen in the spread of the FRET efficiency 
values (a = 0.16) that is wider than any of the other three molecules mentioned above. The 
Glutamate-bound GluR2-SlS2-T686S can have the most open and the most closed 
conformation although its average FRET efficiency of 0.79 is comparable to that of the 
Glutamate-bound GluR2-SlS2. 
It is evident from the denoised ensemble histogram (Figure 12B) of apo GluR2-SlS2 
that there are more than two conformations of the molecule because of the prominent peaks 
at certain points in the histogram. Using HMM (Hidden Markov Model)97 analysis of the 
FRET trajectories of apo GluR2-SlS2 molecules, we attempted to fit the denoised ensemble 
histogram to 2, 3, 4, 5, 6, and 7 conformational states. For each trial fit, we compared the 
FRET efficiency values of the suggested conformational states to those of the individual 
molecules using the single-molecule FRET histograms to evaluate the most consistent fit. We 
identified the five preferred conformational states having FRET efficiency values of 0.94, 
0.84, 0.75, 0.65, and 0.54 (Figure 14). Therefore, the apo GluR2-SlS2 molecule prefers to 
adapt five distinct conformations. 
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i Figure 14. Denoised Apo GluR2-
S1S2 Ensemble FRET Histogram. 
The histogram shows the five 
preferred conformational states and 
the rate constants of the transitions. 
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There are four interconversions that occur in the apo GluR2-SlS2 (Table 3) as a 
result of the five preferred conformational states. The net transition is always to a more 
closed conformational state although the transition from 0.65 to 0.75 (k2 = 6.9 s"1) is slower 
than the reverse transition from 0.75 to 0.65 (k.2 = 8.7 s"1). This may be the reason for the 
high occurrence of the relatively open conformational state with a FRET efficiency value of 
0.65 (Figure 14). Moreover, we observed that the interconversions are most likely between 
two adjoining conformational states so the appropriate model for the process is given below. 
A « - B < = » C - » D o E 
Table 3. Apo GluR2-SlS2 State Transitions 
Equilibrium 
0.54 <-» 0.65 
0.65 <-> 0.75 
0.75<^0.84 
0.84 <-> 0.94 
Transition 
0.54 -> 0.65 
0.65 -> 0.54 
0.65 -> 0.75 
0.75 -> 0.65 
0.75 -> 0.84 
0.84 -> 0.75 
0.84 -> 0.94 
0.94 -> 0.84 
Initial 
Population 
41 
38 
36 
33 
28 
20 
17 
13 
Net Transition 
0.54 -» 0.65 
0.65 -> 0.75 
0.75 -> 0.84 
0.84 - • 0.94 
Through the HaMMy program, we resolved that four is the most plausible number of 
preferred conformational states of the Glutamate-bound GluR2-SlS2 molecule with the 
following FRET efficiency values: 0.90, 0.81, 0.72, and 0.59 (Figure 15). This experimental 
observation was predicted by the MD simulations done by Lau and Roux on GluR2-SlS2 in 
the presence of the ligand Glutamate . Based on those simulations, the 0.59 state is the 
Glutamate-bound open form of GluR2-SlS2 where the ligand Glutamate interacts with only 
SI through P478, T480, and R485. The 0.72 state has additional interactions between the 
ligand Glutamate and the side chains of S654 and E705. The 0.81 state is further stabilized 
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by the hydrogen bond between E402 and T686. Finally, the 0.90 state is the fully closed form 
of the Glutamate-bound GluR2-SlS2 and it is characterized by the addition of the interaction 
between the ligand Glutamate and T655. 
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Figure 15. Denoised Glutamate-
bound GluR2-SlS2 Ensemble 
FRET Histogram. The histogram 
shows the four preferred 
conformational states and the rate 
constants of the transitions. 
Like the apo GluR2-SlS2, all the transitions in the Glutamate-bound GluR2-SlS2 
(Table 4) lead to the more closed conformations. One difference is that all the rate constants 
of the transitions toward the more closed conformations are greater than the rate constants of 
the reverse transitions. Another difference is that the relatively closed conformational state 
with a FRET efficiency value of 0.81 is the most populous state. These observations show 
that ligand Glutamate hastens the closing of the cleft of GluR2-SlS2. The fact that there are 
only four preferred conformational states of the Glutamate-bound GluR2-SlS2 proves that 
the ligand Glutamate stabilizes the GluR2-SlS2 molecule. 
Table 4. Glutamate-bound GluR2-SlS2 State Transitions 
Equilibrium 
0.59-^0.72 
0.72 <-> 0.81 
0.81 <^0.90 
Transition 
0.59 -> 0.72 
0.72-> 0.59 
0.72-> 0.81 
0.81 -> 0.72 
0.81-> 0.90 
0.90 -> 0.81 
Initial 
Population 
43 
34 
51 
46 
41 
40 
Net Transition 
0.59 -> 0.72 
0.72-> 0.81 
0.81 -> 0.90 
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Another experiment aims to assess the importance of T686 in stabilizing the 
Glutamate-bound GluR2-SlS2. As mentioned earlier, the T686 forms a hydrogen bond with 
E402 only when the ligand Glutamate is inside the cleft63. When T686 is replaced with 
Serine (S), the side chain of S is less restricted and forms a less stable hydrogen bond with 
E40264. This is the reason why the Glutamate-bound GluR2-SlS2-T686S can have a 
relatively more open and more closed conformations compared to the apo and the Glutamate-
bound GluR2-SlS2. The five preferred conformational states of the Glutamate-bound 
GluR2-SlS2-T686S have FRET efficiency values of 0.96, 0.82, 0.68, 0.54, and 0.39 (Figure 
16). One conformation with FRET efficiency value of 0.39 is the most open conformational 
state observed among the molecules. The number of conformations is similar to that of the 
apo GluR2-SlS2. However, the apo GluR2-SlS2 tends to stay in more open conformation 
(Figure 14) while the Glutamate-bound GluR2-SlS2-T686S tends to have a narrower cleft 
closure as evidenced by the relatively high occurrence of the conformations with a FRET 
efficiency value of 0.96 (Figure 16). 
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Figure 16. Denoised Glutamate-
bound GluR2-SlS2-T686S 
Ensemble FRET Histogram. 
The histogram shows the five 
preferred conformational states 
and the rate constants of the 
transitions. 
The weakness of the hydrogen bond that holds SI and S2 together is reflected in the 
number of net transitions to a more closed conformation (Table 5). The 0.82 state is supposed 
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to be stabilized by the T686 - E402 interaction. The less stable interaction between S686 and 
E402 is reflected in the zero net transition between the 0.68 state and the 0.82 state. 
Moreover, there are only 6 net transitions even though the transition to a more closed 
conformation is always faster as indicated by the rate constants. The high occurrence of the 
conformations with a FRET efficiency value of 0.96 may be caused by the high forward rate 
constant that favors the transition from 0.82 to 0.96. Another reason may the absence of 
methyl group (-CH3) in the side chain of S compared to the side chain of T (Figure 17). The 
smaller volume occupied by the S residue made the GluR2-SlS2 collapse a little more 
tightly, resulting in the narrower cleft closure. 
Table 5. Glutamate-bound GluR2-SlS2-T686S State Transitions 
Equilibrium 
0.39-H-0.54 
0.54 <-> 0.68 
0.68** 0.82 
0.82 <-> 0.96 
Transition 
0.39 -> 0.54 
0.54 -> 0.39 
0.54-> 0.68 
0.68 -> 0.54 
0.68 -» 0.82 
0.82 -> 0.68 
0.82 -> 0.96 
0.96 -> 0.82 
Initial 
Population 
24 
24 
44 
42 
49 
49 
36 
32 
Net Transition 
0.54 -> 0.68 
0.82 - • 0.96 
Figure 17. Structures of Serine and 
Threonine. The two amino acids have 
polar uncharged side chains. Both of them 
have an alcohol group (-OH). However, 
Threonine has a methyl group (-CH3) in its 
side chain. 
The Glutamate-bound GluR2-SlS2 is well characterized based on MD simulations. 
The four conformational states of the Glutamate-bound GluR2-SlS2 are also observed in the 
HO. HCL ,CH; 
H9N O H2N' 
OH OH 
Serine Threonine 
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apo GluR2-SlS2 and in the Glutamate-bound GluR2-SlS2-T686S (Table 6). The presence of 
the fifth conformational state (0.54) in the apo molecule is due to the absence of the ligand 
Glutamate. On the other hand, the presence of a fifth conformational state in the T686S 
mutant molecule is caused by weak interaction that destabilizes the molecule. 
Table 6. Preferred Conformational States 
Molecule 
ApoSlS2 
SlS2 + Glu 
SlS2-T686S + Glu 
Open <-» Closed 
0.54 
0.39 
0.65 
0.59 
0.54 
0.75 
0.72 
0.68 
0.84 
0.81 
0.82 
0.94 
0.90 
0.96 
The FRET efficiency values in one ensemble histogram provide us some information 
about the range of the distances between the two fluorophores and the conformations of the 
GluR2-SlS2 molecule in general. Using the FRET efficiency trace as a function of time, we 
can calculate the FRET efficiency fluctuation characteristic time scale (T) of the molecule by 
determining the autocorrelation function of the FRET efficiency and fitting it to the 
exponential decay function (Figure 18). Calculating the autocorrelation function is basically 
shifting the function of time by some values called lag times and taking the total area of the 
overlap between the original function and the shifted function. So autocorrelation function is 
a measure of self-similarity. The smaller the lag time, the larger is the overlap. Then we fit 
the autocorrelation function with the exponential decay function y = a2 e"bx, where x is time, a 
is the fluctuation amplitude, and b is the inverse of x . This time scale may characterize the 
distance fluctuation between the donor and acceptor fluorophores and the conformational 
dynamics29 of the GluR2-SlS2 molecule in the presence or absence of Glutamate because the 
dynamics of the molecule is related to its affinity to a ligand65. 
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Figure 18. Autocorrelation Functions. The FRET efficiency as a function of time is 
shifted by some values called lag times. One point in the graph represents the total area of 
the overlap between the original trace and the shifted trace for a particular lag time. The 
solid line shows the exponential decay function. Inset: Table of the FRET efficiency 
fluctuation characteristic time scales (x) and the goodness of fit (R2) with respect to the 
exponential decay function. 
The apo GluR2-SlS2 molecule is not rigid in solution because it does not have a 
ligand. The absence of a ligand results in a lower average FRET efficiency value (0.74) and a 
higher x (0.12 s) for the apo GluR2-SlS2 molecule compared to the Glutamate-bound 
GluR2-SlS2 molecule (Figure 18 Inset). The higher x for the apo GluR2-SlS2 molecule 
indicates that the molecule has a slower inter-dye distance fluctuation and a slower transition 
from one conformation to another. This observation is consistent with results of Ha, et al.29 
where the x for one enzyme increased when an active-site inhibitor is bound to the said 
enzyme because the inhibitor made the enzyme more open. Moreover, the amplitude of the 
autocorrelation function is directly proportional to the degree of floppiness of the molecule as 
shown by the a values of the molecules (Figure 18). 
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The Glutamate-bound molecules (GluR2-SlS2 and GluR2-SlS2-T686S) have almost 
the same average FRET efficiency values (0.80 and 0.79, respectively). The x for both of the 
molecules is 0.11 s, indicating that Glutamate can influence the conformational dynamics of 
the said molecules. The lower x for these molecules compared to that of the apo GluR2-SlS2 
molecule may be caused by the ligand Glutamate that exerts a pull on the two lobes (SI and 
S2), making them more dynamic. 
The above descriptions of the conformational dynamics of the molecules have never 
been observed in the previous structural spectroscopic studies of the said molecules in 
solution medium91'101. Finally, all the protein molecules used in this study are floppy when 
compared to the more rigid HIV-1 TAR DNA , which has very minimal FRET efficiency 
fluctuation. 
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4. CONCLUSION 
This thesis contains the results of the groundbreaking characterization of the 
dynamics of the conformational changes of the ligand-binding domain (S1S2) of the GluR2 
subunit of the AMPA receptor using smFRET technique. The results indicate that the ligand 
Glutamate stabilizes the closed conformation of the GluR2-SlS2. The closing of the cleft 
between SI and S2 is a four-step transition process where each state is reinforced by 
interactions between the ligand Glutamate and S1S2 residue or between two S1S2 residues. 
The presence of four states is consistent with the previously reported MD simulations by 
another research group. The four states make the Glutamate-bound GluR2-SlS2 a floppy 
molecule compared to the closed HIV-1 TAR DNA. The apo GluR2-SlS2 and the 
Glutamate-bound GluR2-SlS2-T686S are even more floppy molecules because each of them 
has five states. Although the molecules seem to be flexible, the interconversions can only 
happen between two adjacent states. Lastly, the flexibility of the molecules was further 
described by the characteristic time scale (x) of the inter-dye distance fluctuation. The apo 
GluR2-SlS2 is more relaxed than the Glutamate-bound GluR2-SlS2. The Glutamate-bound 
GluR2-SlS2-T686S behaves like the Glutamate-bound GluR2-SlS2 in terms of 
conformational fluctuation due to the presence of the ligand Glutamate. 
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